Bulk order Acrobiosystems for Chinese

Chinese

A-Z

Siglec-15 | CD20 | FGL1 | CD19 | PD-1 | BCMA

There is no goods in the shopping cart !

My Cart

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9

Home
Product & Service

Products by Category

Recombinant proteins and more
Immune Checkpoint ProteinsHot Targets of CAR-T Cell TherapyNew Biosimilar Drug TargetsHot Anti-idiotypic AntibodyHot Fc Receptor Proteins Llama IgG Fc Fusion ProteinNew Bio-Markers & CD Antigens ActiveMax -Best Cytokines Viral Proteins Enzymes Antibodies All Recombinant Proteins
Services

Innovation Lab ServicesNew

Pre-labeled proteins
Biotinylated protein collectionHot FITC & PE labeled ProteinsNew Fluorescent fusion proteins
Kits
ELISA Assay Kits for Quantitative Analysis of Therapeutic Antibodies in Serum SamplesNew Inhibitor Screening Kits Five-Minute MAB Isotyping Kits
Others
HPLC-verified Proteins

Hot Products

mAb for Anti-CD20 CAR Detection - Flow Cytometry ValidatedNew Siglec-15 - Validated by Cell-based Assay BLI/ SPR/ ELISANew Integrin - Integrin ProteinsNew CD20 - Full Length ProteinExclusive FGL1 - Fibrinogen-like protein 1New PD1 - PD1 Pathway TargetsHot CD19 - High Affinity CD19, Designed for Detection of Anti-CD19 CAR ExpressionNew CD3E - Biotinylated CD3E productsHot BCMA - B-Cell Maturation Antigen TIGIT - TIGIT Signaling Axis CD47 - Leukocyte Surface Antigen CD47 LAG3 - Lymphocyte-activation gene 3 ROR - Recombinant ROR1 & ROR2
Support

How to Order Shipping & Payments Global Distributors Testimonials Download Brochures Download COA
Application

Quantitative Analysis of mAb in Serum Evaluation of CAR Expression
X-LAB
Company

About Us Join Us Contact Us
Activity

News Exhibitions Promotion

Your Position: Home > KIR2DL3

KIR2DL3

KIR2DL3 Molecule Information

Name:Killer cell immunoglobulin-like receptor 2DL3
Target Synonym:NKAT2b;p58 natural killer cell receptor clone CL-6;Killer inhibitory receptor cl 2-3;NKAT2a;MHC class I NK cell receptor;NKAT-2;KIRCL23;Natural killer-associated transcript 2;p58 NK receptor CL-6;KIR2DL3;p58.2 MHC class-I-specific NK receptor;CD158B2 ;KIR

Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase ?

KIR2DL3 Protein Product ListCompare or Buy

Product> Filter Results

Cat. No.	Species	Product Description	Structure	Purity	Feature
KI3-H5257	Human	Human KIR2DL3 / CD158b2 Protein, Fc Tag
KI3-H5226	Human	Human KIR2DL3 / CD158b2 Protein, His Tag

KIR2DL3 Molecule Synonym Name

KIR2DL3,CD158B2,KIRCL23,NKAT2,KIR-023GB,NKAT2a,NKAT2b,NKAT-2,CD158 B2,GL183,KIR-023GB,KIR-K7b,KIR-K7c,KIRCL23,NKAT,p58

KIR2DL3 Molecule Background

Killer cell immunoglobulin-like receptor 2DL3 (KIR2DL3) is also known as CD158 antigen-like family member B2, KIR-023GB, Killer inhibitory receptor cl 2-3, MHC class I NK cell receptor, NKAT2a, NKAT2b, Natural killer-associated transcript 2, p58 natural killer cell receptor clone CL-6, p58.2 MHC class-I-specific NK receptor, CD158b2 and KIR2DL3, which is a single-pass type I membrane protein and belongs to the immunoglobulin superfamily.KIR2DL3 is a receptor on natural killer (NK) cells for HLA-C alleles (HLA-Cw1, HLA-Cw3 and HLA-Cw7). KIR2DL3 can inhibit the activity of NK cells thus preventing cell lysis.

KIR2DL3 References

KIR2DL3 Clinical Drug Information

Name	Research Code	Research Phase	Company	Indications	Clinical Trials
Lirilumab	BMS-986015; IPH-21; IPH-2101; IPH-2102; NN-1975	Phase Ⅱ	Novo Nordisk, Bristol-Myers Squibb, Ono Pharmaceutical, Innate	Myelodysplastic syndrome (MDS), Chronic lymphocytic leukemia (CLL), hematological malignancies, Solid tumours, Multiple myeloma (MM), Acute myeloid Leukemia (AML)	Details